Web Analytics

Investor Profile

Advent Life Sciences

Advent Life Sciences United Kingdom - London
INVESTOR

1 Disclosed Funding Rounds $40,000,000
6 Participating Investments




Advent Life Sciences is one of the leading trans-Atlantic venture investors focused on building innovative Life Sciences businesses in the UK, Europe and the USA. We are a highly experienced

Invested In

Company Date Round Raised
  Beacon Therapeutics July, 10 ,2024 Series B $170,000,000
  Moximed August, 16 ,2022 Series C $40,000,000
  Proximie August, 14 ,2022 Series C $80,000,000
  Nalu Medical, Inc. January, 05 ,2024 Unknown $65,000,000
  Curve Therapeutics February, 28 ,2024 Series A $51,183,495
  Beacon Therapeutics July, 10 ,2024 Series B $170,000,000